GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (OTCPK:SHPMY) » Definitions » Days Sales Outstanding

SHPMY (Shanghai Pharmaceuticals Holding Co) Days Sales Outstanding : 105.83 (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Days Sales Outstanding?

Shanghai Pharmaceuticals Holding Co's average Accounts Receivable for the three months ended in Mar. 2025 was $11,321 Mil. Shanghai Pharmaceuticals Holding Co's Revenue for the three months ended in Mar. 2025 was $9,761 Mil. Hence, Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 105.83.

The historical rank and industry rank for Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding or its related term are showing as below:

SHPMY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 76.37   Med: 90.64   Max: 108.43
Current: 108.43

During the past 13 years, Shanghai Pharmaceuticals Holding Co's highest Days Sales Outstanding was 108.43. The lowest was 76.37. And the median was 90.64.

SHPMY's Days Sales Outstanding is ranked worse than
75.45% of 110 companies
in the Medical Distribution industry
Industry Median: 75.245 vs SHPMY: 108.43

Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding increased from Mar. 2024 (100.68) to Mar. 2025 (105.83).

Shanghai Pharmaceuticals Holding Co Days Sales Outstanding Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Days Sales Outstanding Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 92.13 92.58 102.56 99.07 101.77

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.68 107.24 105.28 114.45 105.83

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding falls into.


;
;

Shanghai Pharmaceuticals Holding Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (10214.543 + 10868.351) / 2 ) / 37805.559*365
=10541.447 / 37805.559*365
=101.77

Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding (Q: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (10868.351 + 11774.164) / 2 ) / 9761.29*365 / 4
=11321.2575 / 9761.29*365 / 4
=105.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co  (OTCPK:SHPMY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Shanghai Pharmaceuticals Holding Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (OTCPK:SHPMY) » Definitions » Days Sales Outstanding
Comparable Companies
SHSE:600332 SHSE:600998 SHSE:600511 SHSE:600739 SHSE:600056 SZSE:000028 SZSE:301015 SZSE:000950 SHSE:603368 SZSE:002589 MCK COR CAH ASX:SIG HSIC HKSE:01099 XSWX:GALE MIL:AMP NZSE:EBO TSE:7459
Traded in Other Exchanges
SHPMF:USA 02607:Hong Kong S1R:Germany 601607:China
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Website
https://www.sphchina.com
Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2024, medical distribution is the largest segment, accounting for 91.3% of total revenue. It also has coverage of 31 provinces and cities nationwide.